The Week in Review: February 23, 2018 – March 2, 2018
One in four Canadians affected by liver disease; Ontario implements expanded access; VA in USA on target to eliminate HCV; Six in ten in Ireland with HCV undiagnosed!; alpha-fetoprotein may detect HCC sooner; DAAs protect against liver cancer in those with SVR, and improve HCV-related liver transplant outcomes; HBV ALT cutoff points and mortality.
The Week in Review: February 16, 2018 – February 23, 2018
Ontario removes fibrosis restrictions, smoking tobacco and HCV, drinking alcohol and HCV, DAAs and reduced mortality, protective effect of marijuana on the liver.
The Week in Review: February 9, 2018 – February 16, 2018
HCV and heart disease, HCV around the world, need for universal screening, HBV, and more…
The Week in Review: February 2, 2018 – February 9, 2018
CTAC Launches Campaign to End Hepatitis C in Canada; #EASLmono: Expanding the conversation on hepatitis elimination; HCV in Older Adults: Effects of Prolonged Infection, Aging-Related Mechanisms, and Treatment; HCV hospitalizations increasing among baby boomers, men, drug users; Attention Hepatitis B (HBV) Patients & Caregivers – Your Help Requested. HepCBC needs to hear your voice; 7 recent reports on HBV treatment approvals, efficacy, and more…